July 07, 2017
Bioanalysis of the future: live streaming from Reid Bioanalytical Forum by Bioanalysis Zone
Bioanalysis Zone embarks on a new venture as it announces the live streaming of the first session of Reid Bioanalytical Forum, ‘Bioanalysis of the future’, as part of its wider conference coverage.
Bioanalysis Zone is supporting The Chromatographic Society at the 22nd International Reid Bioanalytical Forum (Cambourne, UK; 4–7 September) and has announced that it will live-stream the first session.
The broadcasted session will address the possible future of bioanalysis with leading industry bioanalysts presenting their latest findings on novel and leading-edge technologies.
Tony Edge (Agilent Technologies, UK), one of the conference organizers, commented: “I have the pleasure of chairing the first session at the Reid International Forum this year. The presenters will be Amanda Wilson from AstraZeneca, Scott Summerfield from GSK and Lee Mendil from Cancer Research UK.
“The second half of the session introduces a new format for the Reid Forum; the subsequent five presentations will be from manufacturers giving their brief insights into the future of bioanalysis. Each vendor will have a specific focus covering the full workflow, ranging from sampling, sample preparation, chromatography and finally detection.”
During the second part of the session, the floor will be open to audience participation, including an open debate and what is hoped will be an engaging question and answer session. Edge concluded: “It is an exciting opportunity to ask questions of leading manufacturers and get involvement of the wider bioanalytical community.”
As well as the live streaming, Bioanalysis Zone will also publish exclusive content and other presentations directly from the conference, giving those registered priority access to the latest news, information and developments.
In order to access the live stream, exclusive content and ask questions from wherever you are in the world, register your interest here.
About Bioanalysis Zone
Since launching in 2011, Bioanalysis Zone has attracted over 6,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research exclusive interviews and commentaries.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio includes two imprints: Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.